| Isdin Eryfotona Fluid with SPF 100+ AK-NMSC, 50 ml • liki24.co.uk | 39.30 RON |
| Isdin Eryfotona Fluid mit LSF 100+ AK-NMSC, 50 ml • liki24.at | 47.20 RON |
| Isdin Fluido Eryfotona con FPS 100+ AK-NMSC, 50 ml • liki24.es | 47.20 RON |
Fluid with SPF 100+ Eryfotona AK-NMSC, 50 ml, Isdin Properties: - adjuvant treatment for the protection and prevention of actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC) indicated in people at risk of developing AK or other forms of NMSC, such as phototype I and II or in those who have undergone or are undergoing treatment for AK or other forms of NMSC; - reduces and improves the appearance of the subclinical skin cancer field associated with actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC); - forms a protective film on the skin with Repairsomes(R), which contains photolyase encapsulated in liposomes and UV filters (SPF 109, UVA in-vitro 39) that absorb, reflect and disperse solar radiation; - this is a medical device; - before use, please read the information on the packaging and the leaflet inside the box. Active ingredients: Repairsomes (UVB-UVA filter complex + plankton extract), bisabolol, tocopheryl acetate, panthenol, sufficient amount of excipients. How to use: Shake before use. Apply twice a day to the affected areas, morning and afternoon. During sun exposure, reapply every two hours. Precautions: Apply only to clean and intact skin. Apply at least 20 minutes before other dermatological products. In patients undergoing pharmacologic or surgical treatment for AK or NMSC, treatment with Eryfotona(R) AK-NMSC fluid should be initiated after lesion closure. Continued daily use is required to adjunctively prevent and treat AK and NMCS. Contraindications: Actinic keratosis (AK) and other forms of non-melanoma skin cancer (NMSC) are caused by chronic exposure to sunlight. If you have had AK or other forms of NMSC, you should avoid direct sun exposure. There is no information on the use of Eryfotona(R) AK-NMSC fluid in children, in women during pregnancy or breastfeeding. Avoid contact with eyes and mucous membranes. In case of an adverse reaction to any of the ingredients, discontinue treatment and consult your doctor. Presentation: 50 ml